Skip to content

Ido Hartogsohn

The Program for Science, Technology and Society Studies, Bar Ilan University, Ramat Gan, Israel.

11 papers in the library · 158 citations · publishing 2018-2026

Papers

Set and Setting in the Santo Daime

Frontiers in Pharmacology May 4, 2021 Ido Hartogsohn 49 citations

The psychedelic experience is profoundly shaped by psychological, social, and cultural factors—a concept known as set and setting. The Santo Daime religion in Brazil uses a rich tapestry of ordering principles, techniques, symbology, aesthetics, and music to direct the effects of the hallucinogenic brew ayahuasca. This paper systematically describes these elements and the mechanics of entheogenic initiation within the tradition, providing a template for future studies on how context influences psychedelic experimentation.

American Trip

The MIT Press eBooks July 14, 2020 Ido Hartogsohn 34 citations

In midcentury America, the psychedelic experience was profoundly shaped by historical, social, and cultural forces—by the user's mindset and the surrounding environment. Researchers studied psychedelics as therapeutic medicines, dangerous drugs, tools for spiritual communion, cognitive enhancers, and political catalysts, often reaching contradictory results. The book chronicles uses from CIA and military experimentation to influences on music, fashion, design, architecture, and film, introducing figures like psychologist Betty Eisner and Timothy Leary. It situates these developments within the cold war, counterculture, anti-psychiatric movement, and cybernetics, proposing that LSD functioned as a suggestible technology and that midcentury America's collective set and setting created the conditions for a distinct American trip.

Set and setting in microdosing: an oft-overlooked principle.

Psychopharmacology December 1, 2022 Ido Hartogsohn, Rotem Petranker 22 citations

The use of psychedelics for medical and recreational purposes is rising, and contextual factors such as expectancy, intention, and sensory and social environment (set and setting) are widely recognized as moderating the effects of these substances. However, clinical trials of microdosing—ingesting small, sub-hallucinogenic doses of psychedelics—rarely report their set and setting, suggesting these factors are not considered important in that context. This paper challenges that assumption and argues for the crucial relevance of set and setting in microdosing practice. Building on set and setting theory and placebo theory, it explains why set and setting are crucial for determining microdosing outcomes and helps explain contradictory results in recent research. Reporting set and setting would make microdosing research more reliable and consistent.

Cyberdelics in context: On the prospects and challenges of mind-manifesting technologies.

Frontiers in psychology January 1, 2022 Ido Hartogsohn 19 citations

The concept of cyberdelics, linking digital technologies with psychedelic drugs, re-emerges alongside renewed interest in virtual reality and psychedelics. Advocates envision transformative technologies fostering awe and transcendence rather than consumerism, but cultural and economic conditions may suppress this potential. Drawing on psychedelic humanities, which emphasize how cultural context (set and setting) shapes drug effects, the paper examines how these principles apply to cyberdelic media, its prospects, and its challenges.

Set and Setting for Psychedelic Harm Reduction

Psychedelic Harm Reduction January 1, 2026 Ido Hartogsohn 13 citations

The concept of set and setting is central to psychedelic studies, referring to how mindset and environment shape psychedelic experiences and their outcomes. This paper proposes a framework for understanding set and setting in relation to harm reduction. It describes four modalities—therapeutic, clinical trial, ritualistic, and recreational—and examines how set and setting differ across them, the implications of these differences, and how harm reduction strategies can be tailored to each. Integrating set and setting principles into public health policies and education could enhance the effectiveness of harm reduction programs for psychedelics.

The Corporadelic Set and Setting

History of Pharmacy and Pharmaceuticals October 1, 2023 Ido Hartogsohn 9 citations

As psychedelics move from Indigenous and underground settings into corporate, for-profit contexts, their meaning and effects change. The term 'corporadelic' describes the appropriation of psychedelics by corporations and their integration into corporate environments. Building on the concept of cultural set and setting, this commentary argues that placing psychedelic medicine within neoliberal consumerism may undermine its efficacy and transformational potential.

Virtual Daime: When Psychedelic Ritual Migrates Online.

Frontiers in psychology January 1, 2022 Ido Hartogsohn 7 citations

When Santo Daime ayahuasca rituals moved online during the COVID-19 pandemic, the shift both enabled continued practice and introduced new challenges. Based on interviews with 12 daimistas who participated in virtual ceremonies via Zoom, the analysis identifies that online rituals allowed religious continuity during social distancing, fostered global community, and opened new avenues for participation and learning. However, participants also reported an impoverished ritual experience marked by greater distractions, technical difficulties, low sensory fidelity, social anxiety, and a tension between social and spiritual dimensions. Concerns about technological mediation, consumerism, commodification, and the digital divide emerged, with limitations amplified by the immersive, body-oriented nature of psychedelic experience.

Psychonauts: Drugs and the making of the modern mind

Journal of Psychedelic Studies February 26, 2024 Ido Hartogsohn 4 citations

The term psychonaut, coined in 1949 by Ernst Jünger, describes individuals who systematically and deliberately explore their own minds, often using psychedelics, distinguishing them from casual experimenters. The concept implies method, commitment, and audacity, and psychedelic history has produced notable figures like Alexander Shulgin who exemplify this approach.

Sanitizing psychedelics: the biopolitics of non-hallucinogenic psychoplastogens

BioSocieties January 8, 2026 Ido Hartogsohn 1 citation

The emergence of non-hallucinogenic psychoplastogens, which promote neuroplasticity without altering consciousness, creates a philosophical divide in psychedelic medicine. Psychedelic-assisted therapy treats subjective experience as central to healing, while psychoplastogens aim to repair brain circuits without inducing altered states. Drawing on socio-technical imaginaries and biopolitics, the paper contrasts these approaches, examining tensions between confronting emotional difficulty and pursuing sanitized, effortless treatment. The controversy reflects competing biopolitical visions of mental health, suffering, and therapeutic transformation, with implications for psychiatry's future.

The mindful use of psychiatric medication: Report from the Tel Aviv Psychoactive Clinic Project and a proposed model for psychiatric care

Journal of Psychedelic Studies January 15, 2025 Ido Hartogsohn, Yaron Yavelberg, Omry Ben Ezra

A pilot study with 110 participants taking psychiatric medications tested workshops that combined education about their condition and medication with guided, mindful ingestion in a supportive group setting. Survey responses from 33 participants showed significantly improved understanding of their medical conditions and prescribed drugs. Interviews revealed strong interest in mindful medication use, benefit from the communal setting, and themes of greater satisfaction and improved ability to benefit from the prescribed drug. The results suggest that non-pharmacological tools can improve outcomes of prescription drug use, supporting the need for further research.

The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity

Frontiers in Neuroscience March 6, 2018 Ido Hartogsohn

Psychedelics appear to enhance the perception of meaning, which may help explain their therapeutic, creativity-boosting, and mystical-type effects. Building on earlier work linking psychedelic-induced meaning enhancement to amplified placebo responses, this paper proposes that similar mechanisms underlie creativity enhancement and mystical experiences. The authors discuss the broader social and public-health implications and suggest directions for further research into how these meaning-amplifying properties work and how they might be harnessed.